yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q36374681-7DFCA2DD-E5BD-4875-9A41-61CFEC3FF917
Q36374681-7DFCA2DD-E5BD-4875-9A41-61CFEC3FF917
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36374681-7DFCA2DD-E5BD-4875-9A41-61CFEC3FF917
H(1)R expression by CD11B(+) cells is not required for susceptibility to experimental allergic encephalomyelitis
P2860
Q36374681-7DFCA2DD-E5BD-4875-9A41-61CFEC3FF917
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36374681-7DFCA2DD-E5BD-4875-9A41-61CFEC3FF917
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e52382b27ce17a62ae376e4e23b04a271d824ade
P2860
Intravenous synthetic peptide MBP8298 delayed disease progression in an HLA Class II-defined cohort of patients with progressive multiple sclerosis: results of a 24-month double-blind placebo-controlled clinical trial and 5 years of follow-up treatm